Pharmacotherapy of Schizophrenia in Acute and Maintenance Phase

KIRLI U., ALPTEKİN K.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, vol.58, 2021 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Review
  • Volume: 58
  • Publication Date: 2021
  • Doi Number: 10.29399/npa.27441
  • Journal Name: NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, Psycinfo, TR DİZİN (ULAKBİM)
  • Keywords: Schizophrenia, psychotic disorders, drug therapy, BIOLOGICAL-PSYCHIATRY WFSBP, REMITTED 1ST-EPISODE PSYCHOSIS, CLINICAL-PRACTICE GUIDELINES, LONG-TERM TREATMENT, WORLD-FEDERATION, PHARMACOLOGICAL-TREATMENT, SCHIZOAFFECTIVE DISORDER, NEGATIVE SYMPTOMS, UPDATE 2012, PART 1
  • Dokuz Eylül University Affiliated: Yes

Abstract

Schizophrenia is one of the leading disorders causing impairment in society. Therefore, it is crucial to review evidence-based treatment approaches which are both effective and causing minimum side effects. In this paper, treatment recommendations for first episode schizophrenia, patients in acute phase with a history of multiple episodes, and patients in the maintenance phase will be discussed in light of the Psychiatric Association of Turkey Guideline for Treatment of Schizophrenia, other recent national and international guidelines as well as expert consensus reports in the literature. Finally, practical considerations will be suggested.